Receptor tyrosine-protein kinase erbB-3, also known as?HER3?(human epidermal growth factor?receptor 3), is a membrane bound?protein?that in humans is encoded by the?ERBB3?gene.?ErbB3?is a member of the epidermal growth factor?receptor?(EGFR/ERBB) family of?receptor tyrosine kinases.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Receptor Tyrosine Protein Kinase ERBB 3 industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
BA-0702
CDX-3379
Elgemtumab
ETBX-031
Others
Market Segment by Product Application
Non-Small Cell Carcinoma
Solid Tumor
Melanoma
Colorectal Cancer
Others
Finally, the report provides detailed profile and data information analysis of leading company.
AstraZeneca Plc
AVEO Pharmaceuticals, Inc.
Etubics Corporation
F. Hoffmann-La Roche Ltd.
GamaMabs Pharma S.A.
GlaxoSmithKline Plc
Hanmi Pharmaceuticals, Co. Ltd.
ImmunoGen, Inc.
Kolltan Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc.
Merus B.V.
Novartis AG
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Sihuan Pharmaceutical Holdings Group Ltd.
Sorrento Therapeutics, Inc.
Symphogen A/S
Takis S.r.l.
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Receptor Tyrosine Protein Kinase ERBB 3 consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Receptor Tyrosine Protein Kinase ERBB 3 market by identifying its various subsegments.
3.Focuses on the key global Receptor Tyrosine Protein Kinase ERBB 3 manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Receptor Tyrosine Protein Kinase ERBB 3 with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Receptor Tyrosine Protein Kinase ERBB 3 submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Receptor Tyrosine Protein Kinase ERBB 3 Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Receptor Tyrosine Protein Kinase ERBB 3 Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Receptor Tyrosine Protein Kinase ERBB 3 Segment by Type
2.1.1 BA-0702
2.1.2 CDX-3379
2.1.3 Elgemtumab
2.1.4 ETBX-031
2.1.5 Others
2.2 Market Analysis by Application
2.2.1 Non-Small Cell Carcinoma
2.2.2 Solid Tumor
2.2.3 Melanoma
2.2.4 Colorectal Cancer
2.2.5 Others
2.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Comparison by Regions (2017-2027)
2.3.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size (2017-2027)
2.3.2 North America Receptor Tyrosine Protein Kinase ERBB 3 Status and Prospect (2017-2027)
2.3.3 Europe Receptor Tyrosine Protein Kinase ERBB 3 Status and Prospect (2017-2027)
2.3.4 China Receptor Tyrosine Protein Kinase ERBB 3 Status and Prospect (2017-2027)
2.3.5 Japan Receptor Tyrosine Protein Kinase ERBB 3 Status and Prospect (2017-2027)
2.3.6 Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Receptor Tyrosine Protein Kinase ERBB 3 Industry Impact
2.5.1 Receptor Tyrosine Protein Kinase ERBB 3 Business Impact Assessment - Covid-19
2.5.2 Market Trends and Receptor Tyrosine Protein Kinase ERBB 3 Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Receptor Tyrosine Protein Kinase ERBB 3 Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Receptor Tyrosine Protein Kinase ERBB 3 Manufacturer Market Share
3.5 Top 10 Receptor Tyrosine Protein Kinase ERBB 3 Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Receptor Tyrosine Protein Kinase ERBB 3 Market
3.7 Key Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Receptor Tyrosine Protein Kinase ERBB 3 Industry Key Manufacturers
4.1 AstraZeneca Plc
4.1.1 Compan Detail
4.1.2 AstraZeneca Plc Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification
4.1.3 AstraZeneca Plc 159 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 AstraZeneca Plc News
4.2 AVEO Pharmaceuticals, Inc.
4.2.1 Compan Detail
4.2.2 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification
4.2.3 AVEO Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 AstraZeneca Plc News
4.3 Etubics Corporation
4.3.1 Compan Detail
4.3.2 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification
4.3.3 Etubics Corporation Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Etubics Corporation News
4.4 F. Hoffmann-La Roche Ltd.
4.4.1 Compan Detail
4.4.2 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification
4.4.3 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 F. Hoffmann-La Roche Ltd. News
4.5 GamaMabs Pharma S.A.
4.5.1 Compan Detail
4.5.2 F. Hoffmann-La Roche Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification
4.5.3 GamaMabs Pharma S.A. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 GamaMabs Pharma S.A. News
4.6 GlaxoSmithKline Plc
4.6.1 Compan Detail
4.6.2 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification
4.6.3 GlaxoSmithKline Plc Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 GlaxoSmithKline Plc News
4.7 Hanmi Pharmaceuticals, Co. Ltd.
4.7.1 Compan Detail
4.7.2 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification
4.7.3 Hanmi Pharmaceuticals, Co. Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 ImmunoGen, Inc.
4.8.1 Compan Detail
4.8.2 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification
4.8.3 ImmunoGen, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 ImmunoGen, Inc. News
4.9 Kolltan Pharmaceuticals, Inc.
4.9.1 Compan Detail
4.9.2 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification
4.9.3 Kolltan Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Kolltan Pharmaceuticals, Inc. News
4.10 Merrimack Pharmaceuticals, Inc.
4.10.1 Compan Detail
4.10.2 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification
4.10.3 Merrimack Pharmaceuticals, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Merrimack Pharmaceuticals, Inc. News
4.11 Merus B.V.
4.11.1 Compan Detail
4.11.2 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification
4.11.3 Merus B.V. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Merus B.V. News
4.12 Novartis AG
4.12.1 Compan Detail
4.12.2 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification
4.12.3 Novartis AG Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Novartis AG News
4.13 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
4.13.1 Company Details
4.13.2 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification
4.13.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. News
4.14 Sihuan Pharmaceutical Holdings Group Ltd.
4.14.1 Compan Detail
4.14.2 Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification
4.14.3 Sihuan Pharmaceutical Holdings Group Ltd. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.14.4 Main Business Overview
4.14.5 Sihuan Pharmaceutical Holdings Group Ltd. News
4.15 Sorrento Therapeutics, Inc.
4.15.1 Compan Detail
4.15.2 Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification
4.15.3 Sorrento Therapeutics, Inc. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.15.4 Main Business Overview
4.15.5 Sorrento Therapeutics, Inc. News
4.16 Symphogen A/S
4.16.1 Compan Detail
4.16.2 Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification
4.16.3 Symphogen A/S Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.16.4 Main Business Overview
4.16.5 Symphogen A/S News
4.17 Takis S.r.l.
4.17.1 Compan Detail
4.17.2 Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification
4.17.3 Takis S.r.l. Receptor Tyrosine Protein Kinase ERBB 3 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.17.4 Main Business Overview
4.17.5 Takis S.r.l. News
4.18.1 Compan Detail
5 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Segment by Big Type
5.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue and Market Share by Big Type (2017-2022)
5.2 BA-0702 Sales Growth Rate and Price
5.2.1 Global BA-0702 Sales Growth Rate (2017-2022)
5.2.2 Global BA-0702 Price (2017-2022)
5.3 CDX-3379 Sales Growth Rate and Price
5.3.1 Global CDX-3379 Sales Growth Rate (2017-2022)
5.3.2 Global CDX-3379 Price (2017-2022)
5.4 Elgemtumab Sales Growth Rate and Price
5.4.1 Global Elgemtumab Sales Growth Rate (2017-2022)
5.4.2 Global Elgemtumab Price (2017-2022)
5.5 ETBX-031 Sales Growth Rate and Price
5.5.1 Global ETBX-031 Sales Growth Rate (2017-2022)
5.5.2 Global ETBX-031 Price (2017-2022)
5.6 Others Sales Growth Rate and Price
5.6.1 Global Others Sales Growth Rate (2017-2022)
5.6.2 Global Others Price (2017-2022)
6 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Segment by Big Application
6.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Big Application (2017-2022)
6.2 Non-Small Cell Carcinoma Sales Growth Rate (2017-2022)
6.3 Solid Tumor Sales Growth Rate (2017-2022)
6.4 Melanoma Sales Growth Rate (2017-2022)
6.5 Colorectal Cancer Sales Growth Rate (2017-2022)
6.6 Others Sales Growth Rate (2017-2022)
7 Global Receptor Tyrosine Protein Kinase ERBB 3 Forecast
7.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue, Sales and Growth Rate (2022-2027)
7.2 Receptor Tyrosine Protein Kinase ERBB 3 Market Forecast by Regions (2022-2027)
7.2.1 North America Receptor Tyrosine Protein Kinase ERBB 3 Market Forecast (2022-2027)
7.2.2 Europe Receptor Tyrosine Protein Kinase ERBB 3 Market Forecast (2022-2027)
7.2.3 China Receptor Tyrosine Protein Kinase ERBB 3 Market Forecast (2022-2027)
7.2.4 Japan Receptor Tyrosine Protein Kinase ERBB 3 Market Forecast (2022-2027)
7.2.5 Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Market Forecast (2022-2027)
7.2.6 Other Regions Receptor Tyrosine Protein Kinase ERBB 3 Market Forecast (2022-2027)
7.3 Receptor Tyrosine Protein Kinase ERBB 3 Market Forecast by Type (2022-2027)
7.3.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Type (2022-2027)
7.3.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share Forecast by Type (2022-2027)
7.4 Receptor Tyrosine Protein Kinase ERBB 3 Market Forecast by Application (2022-2027)
7.4.1 Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Application (2022-2027)
7.4.2 Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Receptor Tyrosine Protein Kinase ERBB 3 Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Receptor Tyrosine Protein Kinase ERBB 3 Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Receptor Tyrosine Protein Kinase ERBB 3
Figure Market Concentration Ratio and Market Maturity Analysis of Receptor Tyrosine Protein Kinase ERBB 3
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Big Type
Figure Global Market Share of Receptor Tyrosine Protein Kinase ERBB 3 by Big Type in 2021
Figure BA-0702 Picture (2017-2022)
Figure CDX-3379 Picture (2017-2022)
Figure Elgemtumab Picture (2017-2022)
Figure ETBX-031 Picture (2017-2022)
Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Big Application
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size by Application
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share by Big Application in 2021
Figure Non-Small Cell Carcinoma Picture
Figure Solid Tumor Picture
Figure Melanoma Picture
Figure Colorectal Cancer Picture
Figure Others Picture
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Comparison by Regions (M USD) (2017-2027)
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Market Size (Million US$) (2017-2027)
Figure North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million US$) Growth Rate (2017-2027)
Figure China Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Receptor Tyrosine Protein Kinase ERBB 3 Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Manufacturer (2017-2022)
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Manufacturer in 2021
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Manufacturer (2017-2022)
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Manufacturer in 2021
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Receptor Tyrosine Protein Kinase ERBB 3 Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Receptor Tyrosine Protein Kinase ERBB 3 Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Receptor Tyrosine Protein Kinase ERBB 3 Market
Table Key Manufacturers Receptor Tyrosine Protein Kinase ERBB 3 Product Type
Table Mergers & Acquisitions Planning
Table AstraZeneca Plc Company Profile
Table Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification of AstraZeneca Plc
Table Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table AVEO Pharmaceuticals, Inc. Company Profile
Table Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification of AVEO Pharmaceuticals, Inc.
Table Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table AVEO Pharmaceuticals, Inc. Recent Development
Table Etubics Corporation Company Profile
Table Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification of Etubics Corporation
Table Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Etubics Corporation Main Business
Table Etubics Corporation Recent Development
Table F. Hoffmann-La Roche Ltd. Company Profile
Table Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification of F. Hoffmann-La Roche Ltd.
Table Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table F. Hoffmann-La Roche Ltd. Main Business
Table F. Hoffmann-La Roche Ltd. Recent Development
Table F. Hoffmann-La Roche Ltd. Main Business
Table F. Hoffmann-La Roche Ltd. Recent Development
Table GamaMabs Pharma S.A. Company Profile
Table Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification of GamaMabs Pharma S.A.
Table Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table GamaMabs Pharma S.A. Main Business
Table GamaMabs Pharma S.A. Recent Development
Table GlaxoSmithKline Plc Company Profile
Table Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification of GlaxoSmithKline Plc
Table Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table GlaxoSmithKline Plc Main Business
Table GlaxoSmithKline Plc Recent Development
Table Hanmi Pharmaceuticals, Co. Ltd. Company Profile
Table Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification of Hanmi Pharmaceuticals, Co. Ltd.
Table Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Hanmi Pharmaceuticals, Co. Ltd. Main Business
Table Hanmi Pharmaceuticals, Co. Ltd. Recent Development
Table ImmunoGen, Inc. Company Profile
Table Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification of ImmunoGen, Inc.
Table Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table ImmunoGen, Inc. Main Business
Table ImmunoGen, Inc. Recent Development
Table Kolltan Pharmaceuticals, Inc. Company Profile
Table Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification of Kolltan Pharmaceuticals, Inc.
Table Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Kolltan Pharmaceuticals, Inc. Main Business
Table Kolltan Pharmaceuticals, Inc. Recent Development
Table Merrimack Pharmaceuticals, Inc. Company Profile
Table Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification of Merrimack Pharmaceuticals, Inc.
Table Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merrimack Pharmaceuticals, Inc. Main Business
Table Merrimack Pharmaceuticals, Inc. Recent Development
Table Merus B.V. Company Profile
Table Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification of Merus B.V.
Table Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merus B.V. Main Business
Table Merus B.V. Recent Development
Table Novartis AG Company Profile
Table Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification of Novartis AG
Table Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novartis AG Main Business
Table Novartis AG Recent Development
Table Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Company Profile
Table Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Table Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Main Business
Table Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Recent Development
Table Sihuan Pharmaceutical Holdings Group Ltd. Company Profile
Table Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification of Sihuan Pharmaceutical Holdings Group Ltd.
Table Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sihuan Pharmaceutical Holdings Group Ltd. Main Business
Table Sihuan Pharmaceutical Holdings Group Ltd. Recent Development
Table Symphogen A/S Company Profile
Table Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification of Symphogen A/S
Table Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Symphogen A/S Main Business
Table Symphogen A/S Recent Development
Table Takis S.r.l. Company Profile
Table Receptor Tyrosine Protein Kinase ERBB 3 Product Introduction, Application and Specification of Takis S.r.l.
Table Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Takis S.r.l. Main Business
Table Takis S.r.l. Recent Development
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2017-2022)
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue and Growth Rate (2017-2022)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Regions (2017-2022)
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Regions in 2021
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Regions (2017-2022)
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Regions in 2021
Figure North America Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2017-2022)
Figure Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2017-2022)
Figure China Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2017-2022)
Figure Japan Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2017-2022)
Figure Southeast Asia Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2017-2022)
Figure Other Regions Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2017-2022)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Big Type (2017-2022)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Big Type (2017-2022)
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Big Type in 2019
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue by Big Type (2017-2022)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Big Type (2017-2022)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue Market Share by Big Type in 2019
Figure Global BA-0702 Sales Growth Rate (2017-2022)
Figure Global BA-0702 Price (2017-2022)
Figure Global CDX-3379 Sales Growth Rate (2017-2022)
Figure Global CDX-3379 Price (2017-2022)
Figure Global Elgemtumab Sales Growth Rate (2017-2022)
Figure Global Elgemtumab Price (2017-2022)
Figure Global ETBX-031 Sales Growth Rate (2017-2022)
Figure Global ETBX-031 Price (2017-2022)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Sales by Big Application (2017-2022)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Big Application (2017-2022)
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Market Share by Big Application in 2019
Figure Global Non-Small Cell Carcinoma Sales Growth Rate (2017-2022)
Figure Global Solid Tumor Sales Growth Rate (2017-2022)
Figure Global Melanoma Sales Growth Rate (2017-2022)
Figure Global Colorectal Cancer Sales Growth Rate (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Sales and Growth Rate (2022-2027)
Figure Global Receptor Tyrosine Protein Kinase ERBB 3 Revenue and Growth Rate (2022-2027)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Regions (2022-2027)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share Forecast by Regions (2022-2027)
Figure North America Sales Receptor Tyrosine Protein Kinase ERBB 3 Market Forecast (2022-2027)
Figure Europe Sales Receptor Tyrosine Protein Kinase ERBB 3 Market Forecast (2022-2027)
Figure China Sales Receptor Tyrosine Protein Kinase ERBB 3 Market Forecast (2022-2027)
Figure Japan Sales Receptor Tyrosine Protein Kinase ERBB 3 Market Forecast (2022-2027)
Figure Southeast Asia Sales Receptor Tyrosine Protein Kinase ERBB 3 Market Forecast (2022-2027)
Figure Other Regions Sales Receptor Tyrosine Protein Kinase ERBB 3 Market Forecast (2022-2027)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Type (2022-2027)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share Forecast by Type (2022-2027)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Sales Forecast by Application (2022-2027)
Table Global Receptor Tyrosine Protein Kinase ERBB 3 Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Receptor Tyrosine Protein Kinase ERBB 3
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Receptor Tyrosine Protein Kinase ERBB 3 Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Receptor Tyrosine Protein Kinase ERBB 3 Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Receptor Tyrosine Protein Kinase ERBB 3 Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Receptor Tyrosine Protein Kinase ERBB 3 Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
AstraZeneca Plc
AVEO Pharmaceuticals, Inc.
Etubics Corporation
F. Hoffmann-La Roche Ltd.
GamaMabs Pharma S.A.
GlaxoSmithKline Plc
Hanmi Pharmaceuticals, Co. Ltd.
ImmunoGen, Inc.
Kolltan Pharmaceuticals, Inc.
Merrimack Pharmaceuticals, Inc.
Merus B.V.
Novartis AG
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Sihuan Pharmaceutical Holdings Group Ltd.
Sorrento Therapeutics, Inc.
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)